During the ' Lightning Round' of Mad Money Thursday night, Jim Cramer weighed in on Teva Pharmaceuticals (TEVA) : "No. We have Bristol-Myers Squibb (BMY) , why do we need Teva?" Let's revisit the charts of BMY to see if the bulls can push BMY to new all-time highs.
More from Investing
There is hope that the worst is over for now, but the danger of failed bounces cannot be quickly dismissed.
If you had missed these last two days you may have missed 48 hours of the most important gains of the year.